Company: NDRA
Filing Date: 2025-07-25
Form Type: S-1/A
Source: 0001654954-25-008477
Chunk: 53

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-25
Form: S-1/A
Chunk 53
---
”). We entered into an underwriting agreement, dated as of , 2025 (the “Underwriting Agreement”), with Lucid with respect to the securities subject to this offering. Subject to the terms and conditions stated in the underwriting agreement, the Underwriter has agreed to purchase, and we have agreed to sell to the Underwriter, the number of securities shown in the table below:

| Underwriter                |     | Number of shares and/or Pre-Funded Warrants |     | Total |
| Lucid Capital Markets, LLC |     |                                             |     |       |
| Total                      |     |                                             |     |       |

The Underwriting Agreement provides that the obligations of the Underwriter to purchase the shares included in this offering are subject to approval of legal matters by counsel and to other conditions. The Underwriting Agreement provides that the Underwriter will purchase all of the securities if any of them are purchased.

Securities sold by the Underwriter to the public will initially be offered at the public offering prices set forth on the cover of this prospectus. In addition, the Underwriter may offer some of the securities to other securities dealers at such price less a concession of $ per share. After the initial offering of the securities, the public offering price or any other term of the offering may be changed by the Underwriter.

Underwriting discounts and commissions

We are offering shares of our common stock and Pre-Funded Warrants pursuant to this prospectus. The following table shows the effective public offering price, underwriting discounts and commissions, and proceeds before expenses to us.

|                                                                                 |     | Effective Price Per Share |     | Effective Price Per Pre-Funded Warrant |     | Total Without Option |     | Total With Option |
|:--------------------------------------------------------------------------------|:----|:--------------------------|:----|:---------------------------------------|:----|:---------------------|:----|:------------------|
| Public offering price                                                           |     | $                         |     | $                                      |     | $                    |     | $                 |
| Underwriting discounts and commissions payable by us, before expenses, to us(1) |     | $                         |     | $                                      |     | $                    |     | $                 |
| Proceeds, before expenses, to us                                                |     | $                         |     | $                                      |     | $                    |     | $                 |

(1) The underwriting discount is 7.0% of the gross proceeds received from the sale of securities to all purchasers in the offering.

Underwriter Warrants